| A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health (NCT07565090) | International AIDS Vaccine Initiative | 2026-05-08 |
| A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health (NCT07425821) | International AIDS Vaccine Initiative | 2026-03-27 |
| Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall Good Health in South Africa. (NCT06694753) | International AIDS Vaccine Initiative | 2025-12-15 |
| A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV. (NCT06617091) | International AIDS Vaccine Initiative | 2025-07-28 |
| A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region. (NCT06272812) | International AIDS Vaccine Initiative | 2025-02-19 |
| A Study to Evaluate the Safety and Immunogenicity of 2 Doses of 100µg BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, Given to a Population of Adults Who Have Received 3 Doses of 300µg BG505 SOSIP.GT1.1 gp140 Vaccine, Adjuvanted (NCT05983874) | International AIDS Vaccine Initiative | 2024-04-16 |
| A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa (NCT05868733) | International AIDS Vaccine Initiative | 2024-03-06 |
| Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health (NCT05724472) | International AIDS Vaccine Initiative | 2023-06-19 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of a Prophylactic HIV Vaccine Candidate (NCT05863585) | International AIDS Vaccine Initiative | 2023-06-01 |
| A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core) (NCT05001373) | International AIDS Vaccine Initiative | 2021-11-12 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath (NCT04794218) | International AIDS Vaccine Initiative | 2021-06-23 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults (NCT04224701) | International AIDS Vaccine Initiative | 2020-08-01 |
| Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence (NCT03512249) | International AIDS Vaccine Initiative | 2019-01-31 |
| Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults (NCT04173819) | International AIDS Vaccine Initiative | 2019-01-25 |
| A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults (NCT03721510) | International AIDS Vaccine Initiative | 2018-12-03 |
| A Phase I Trial to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted (NCT03547245) | International AIDS Vaccine Initiative | 2018-06-15 |
| MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa (NCT02933281) | International AIDS Vaccine Initiative | 2018-05-14 |
| A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults (NCT03205917) | International AIDS Vaccine Initiative | 2017-10-23 |